OptiBiotix Health PLC (AIM:OPTI) has announced three key appointments as it continues to gain commercial traction for its human microbiome-focused compounds for weight management, cholesterol and fitness.
Zac Sniderman is taking on the role of business development and sales director in North America, Shiraz Butt is to be the company’s e-commerce director and Karl Burkitt the marketing director.
They all bring with them significant industry and specialist expertise.
René Kamminga, chief executive of the OptiBiotix Ltd business unit, said: "In the past 12 months we have established the credibility and brand awareness of our science, based ingredients SlimBiome, OptiBiome, LeanBiome and LPLDL ingredients, significantly growing sales to a wider number of reputable global brands in multiple markets.
“These appointments are a further investment to accelerate the growth of the company and to broaden and deepen our income streams with a particular focus on North America and e-commerce."